Global Female Sexual Dysfunction Treatment Market Growth (Status and Outlook) 2025-2031

December 2025 | 80 pages | ID: G8F1713AD686EN
LP Information

Abstracts

According to this study, the global Female Sexual Dysfunction Treatment market size will reach US$ 1375 million by 2031.

Sexual dysfunction is difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Female Sexual Dysfunction Treatment Industry Forecast” looks at past sales and reviews total world Female Sexual Dysfunction Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Female Sexual Dysfunction Treatment sales for 2025 through 2031. With Female Sexual Dysfunction Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Female Sexual Dysfunction Treatment industry.

This Insight Report provides a comprehensive analysis of the global Female Sexual Dysfunction Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Female Sexual Dysfunction Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Female Sexual Dysfunction Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Female Sexual Dysfunction Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Female Sexual Dysfunction Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Female Sexual Dysfunction Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Non-hormonal Therapy
• Hormonal Therapy

Segmentation by Application:

• Sexual Desire Disorders
• Sexual Arousal Disorders
• Orgasm Disorders
• Sexual Pain Disorders
• Post-orgasmic Diseases
• Pelvic Floor Dysfunction
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• AMAG Pharmaceuticals Inc.
• Duchesnay Inc.
• Emotional Brain BV
• Novo Nordisk AS
• Sprout Pharmaceuticals Inc.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Female Sexual Dysfunction Treatment Market Size (2020-2031)
  2.1.2 Female Sexual Dysfunction Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Female Sexual Dysfunction Treatment by Country/Region (2020, 2024 & 2031)
2.2 Female Sexual Dysfunction Treatment Segment by Type
  2.2.1 Non-hormonal Therapy
  2.2.2 Hormonal Therapy
2.3 Female Sexual Dysfunction Treatment Market Size by Type
  2.3.1 Female Sexual Dysfunction Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Female Sexual Dysfunction Treatment Market Size Market Share by Type (2020-2025)
2.4 Female Sexual Dysfunction Treatment Segment by Application
  2.4.1 Sexual Desire Disorders
  2.4.2 Sexual Arousal Disorders
  2.4.3 Orgasm Disorders
  2.4.4 Sexual Pain Disorders
  2.4.5 Post-orgasmic Diseases
  2.4.6 Pelvic Floor Dysfunction
  2.4.7 Other
2.5 Female Sexual Dysfunction Treatment Market Size by Application
  2.5.1 Female Sexual Dysfunction Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Female Sexual Dysfunction Treatment Market Size Market Share by Application (2020-2025)

3 FEMALE SEXUAL DYSFUNCTION TREATMENT MARKET SIZE BY PLAYER

3.1 Female Sexual Dysfunction Treatment Market Size Market Share by Player
  3.1.1 Global Female Sexual Dysfunction Treatment Revenue by Player (2020-2025)
  3.1.2 Global Female Sexual Dysfunction Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Female Sexual Dysfunction Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 FEMALE SEXUAL DYSFUNCTION TREATMENT BY REGION

4.1 Female Sexual Dysfunction Treatment Market Size by Region (2020-2025)
4.2 Global Female Sexual Dysfunction Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Female Sexual Dysfunction Treatment Market Size Growth (2020-2025)
4.4 APAC Female Sexual Dysfunction Treatment Market Size Growth (2020-2025)
4.5 Europe Female Sexual Dysfunction Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Female Sexual Dysfunction Treatment Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Female Sexual Dysfunction Treatment Market Size by Country (2020-2025)
5.2 Americas Female Sexual Dysfunction Treatment Market Size by Type (2020-2025)
5.3 Americas Female Sexual Dysfunction Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Female Sexual Dysfunction Treatment Market Size by Region (2020-2025)
6.2 APAC Female Sexual Dysfunction Treatment Market Size by Type (2020-2025)
6.3 APAC Female Sexual Dysfunction Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Female Sexual Dysfunction Treatment Market Size by Country (2020-2025)
7.2 Europe Female Sexual Dysfunction Treatment Market Size by Type (2020-2025)
7.3 Europe Female Sexual Dysfunction Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Female Sexual Dysfunction Treatment by Region (2020-2025)
8.2 Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL FEMALE SEXUAL DYSFUNCTION TREATMENT MARKET FORECAST

10.1 Global Female Sexual Dysfunction Treatment Forecast by Region (2026-2031)
  10.1.1 Global Female Sexual Dysfunction Treatment Forecast by Region (2026-2031)
  10.1.2 Americas Female Sexual Dysfunction Treatment Forecast
  10.1.3 APAC Female Sexual Dysfunction Treatment Forecast
  10.1.4 Europe Female Sexual Dysfunction Treatment Forecast
  10.1.5 Middle East & Africa Female Sexual Dysfunction Treatment Forecast
10.2 Americas Female Sexual Dysfunction Treatment Forecast by Country (2026-2031)
  10.2.1 United States Market Female Sexual Dysfunction Treatment Forecast
  10.2.2 Canada Market Female Sexual Dysfunction Treatment Forecast
  10.2.3 Mexico Market Female Sexual Dysfunction Treatment Forecast
  10.2.4 Brazil Market Female Sexual Dysfunction Treatment Forecast
10.3 APAC Female Sexual Dysfunction Treatment Forecast by Region (2026-2031)
  10.3.1 China Female Sexual Dysfunction Treatment Market Forecast
  10.3.2 Japan Market Female Sexual Dysfunction Treatment Forecast
  10.3.3 Korea Market Female Sexual Dysfunction Treatment Forecast
  10.3.4 Southeast Asia Market Female Sexual Dysfunction Treatment Forecast
  10.3.5 India Market Female Sexual Dysfunction Treatment Forecast
  10.3.6 Australia Market Female Sexual Dysfunction Treatment Forecast
10.4 Europe Female Sexual Dysfunction Treatment Forecast by Country (2026-2031)
  10.4.1 Germany Market Female Sexual Dysfunction Treatment Forecast
  10.4.2 France Market Female Sexual Dysfunction Treatment Forecast
  10.4.3 UK Market Female Sexual Dysfunction Treatment Forecast
  10.4.4 Italy Market Female Sexual Dysfunction Treatment Forecast
  10.4.5 Russia Market Female Sexual Dysfunction Treatment Forecast
10.5 Middle East & Africa Female Sexual Dysfunction Treatment Forecast by Region (2026-2031)
  10.5.1 Egypt Market Female Sexual Dysfunction Treatment Forecast
  10.5.2 South Africa Market Female Sexual Dysfunction Treatment Forecast
  10.5.3 Israel Market Female Sexual Dysfunction Treatment Forecast
  10.5.4 Turkey Market Female Sexual Dysfunction Treatment Forecast
10.6 Global Female Sexual Dysfunction Treatment Forecast by Type (2026-2031)
10.7 Global Female Sexual Dysfunction Treatment Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Female Sexual Dysfunction Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 AMAG Pharmaceuticals Inc.
  11.1.1 AMAG Pharmaceuticals Inc. Company Information
  11.1.2 AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Product Offered
  11.1.3 AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 AMAG Pharmaceuticals Inc. Main Business Overview
  11.1.5 AMAG Pharmaceuticals Inc. Latest Developments
11.2 Duchesnay Inc.
  11.2.1 Duchesnay Inc. Company Information
  11.2.2 Duchesnay Inc. Female Sexual Dysfunction Treatment Product Offered
  11.2.3 Duchesnay Inc. Female Sexual Dysfunction Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Duchesnay Inc. Main Business Overview
  11.2.5 Duchesnay Inc. Latest Developments
11.3 Emotional Brain BV
  11.3.1 Emotional Brain BV Company Information
  11.3.2 Emotional Brain BV Female Sexual Dysfunction Treatment Product Offered
  11.3.3 Emotional Brain BV Female Sexual Dysfunction Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Emotional Brain BV Main Business Overview
  11.3.5 Emotional Brain BV Latest Developments
11.4 Novo Nordisk AS
  11.4.1 Novo Nordisk AS Company Information
  11.4.2 Novo Nordisk AS Female Sexual Dysfunction Treatment Product Offered
  11.4.3 Novo Nordisk AS Female Sexual Dysfunction Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Novo Nordisk AS Main Business Overview
  11.4.5 Novo Nordisk AS Latest Developments
11.5 Sprout Pharmaceuticals Inc.
  11.5.1 Sprout Pharmaceuticals Inc. Company Information
  11.5.2 Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Product Offered
  11.5.3 Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Sprout Pharmaceuticals Inc. Main Business Overview
  11.5.5 Sprout Pharmaceuticals Inc. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Female Sexual Dysfunction Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Female Sexual Dysfunction Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Non-hormonal Therapy
Table 4. Major Players of Hormonal Therapy
Table 5. Female Sexual Dysfunction Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Female Sexual Dysfunction Treatment Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Female Sexual Dysfunction Treatment Market Size Market Share by Type (2020-2025)
Table 8. Female Sexual Dysfunction Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Female Sexual Dysfunction Treatment Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Female Sexual Dysfunction Treatment Market Size Market Share by Application (2020-2025)
Table 11. Global Female Sexual Dysfunction Treatment Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Female Sexual Dysfunction Treatment Revenue Market Share by Player (2020-2025)
Table 13. Female Sexual Dysfunction Treatment Key Players Head office and Products Offered
Table 14. Female Sexual Dysfunction Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Female Sexual Dysfunction Treatment Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Female Sexual Dysfunction Treatment Market Size Market Share by Region (2020-2025)
Table 19. Global Female Sexual Dysfunction Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Female Sexual Dysfunction Treatment Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Female Sexual Dysfunction Treatment Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Female Sexual Dysfunction Treatment Market Size Market Share by Country (2020-2025)
Table 23. Americas Female Sexual Dysfunction Treatment Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Female Sexual Dysfunction Treatment Market Size Market Share by Type (2020-2025)
Table 25. Americas Female Sexual Dysfunction Treatment Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Female Sexual Dysfunction Treatment Market Size Market Share by Application (2020-2025)
Table 27. APAC Female Sexual Dysfunction Treatment Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Female Sexual Dysfunction Treatment Market Size Market Share by Region (2020-2025)
Table 29. APAC Female Sexual Dysfunction Treatment Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Female Sexual Dysfunction Treatment Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Female Sexual Dysfunction Treatment Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Female Sexual Dysfunction Treatment Market Size Market Share by Country (2020-2025)
Table 33. Europe Female Sexual Dysfunction Treatment Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Female Sexual Dysfunction Treatment Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Female Sexual Dysfunction Treatment
Table 39. Key Market Challenges & Risks of Female Sexual Dysfunction Treatment
Table 40. Key Industry Trends of Female Sexual Dysfunction Treatment
Table 41. Global Female Sexual Dysfunction Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Female Sexual Dysfunction Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Female Sexual Dysfunction Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Female Sexual Dysfunction Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. AMAG Pharmaceuticals Inc. Details, Company Type, Female Sexual Dysfunction Treatment Area Served and Its Competitors
Table 46. AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Product Offered
Table 47. AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. AMAG Pharmaceuticals Inc. Main Business
Table 49. AMAG Pharmaceuticals Inc. Latest Developments
Table 50. Duchesnay Inc. Details, Company Type, Female Sexual Dysfunction Treatment Area Served and Its Competitors
Table 51. Duchesnay Inc. Female Sexual Dysfunction Treatment Product Offered
Table 52. Duchesnay Inc. Female Sexual Dysfunction Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Duchesnay Inc. Main Business
Table 54. Duchesnay Inc. Latest Developments
Table 55. Emotional Brain BV Details, Company Type, Female Sexual Dysfunction Treatment Area Served and Its Competitors
Table 56. Emotional Brain BV Female Sexual Dysfunction Treatment Product Offered
Table 57. Emotional Brain BV Female Sexual Dysfunction Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Emotional Brain BV Main Business
Table 59. Emotional Brain BV Latest Developments
Table 60. Novo Nordisk AS Details, Company Type, Female Sexual Dysfunction Treatment Area Served and Its Competitors
Table 61. Novo Nordisk AS Female Sexual Dysfunction Treatment Product Offered
Table 62. Novo Nordisk AS Female Sexual Dysfunction Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Novo Nordisk AS Main Business
Table 64. Novo Nordisk AS Latest Developments
Table 65. Sprout Pharmaceuticals Inc. Details, Company Type, Female Sexual Dysfunction Treatment Area Served and Its Competitors
Table 66. Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Product Offered
Table 67. Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Sprout Pharmaceuticals Inc. Main Business
Table 69. Sprout Pharmaceuticals Inc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Female Sexual Dysfunction Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Female Sexual Dysfunction Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Female Sexual Dysfunction Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Female Sexual Dysfunction Treatment Sales Market Share by Country/Region (2024)
Figure 8. Female Sexual Dysfunction Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Female Sexual Dysfunction Treatment Market Size Market Share by Type in 2024
Figure 10. Female Sexual Dysfunction Treatment in Sexual Desire Disorders
Figure 11. Global Female Sexual Dysfunction Treatment Market: Sexual Desire Disorders (2020-2025) & ($ millions)
Figure 12. Female Sexual Dysfunction Treatment in Sexual Arousal Disorders
Figure 13. Global Female Sexual Dysfunction Treatment Market: Sexual Arousal Disorders (2020-2025) & ($ millions)
Figure 14. Female Sexual Dysfunction Treatment in Orgasm Disorders
Figure 15. Global Female Sexual Dysfunction Treatment Market: Orgasm Disorders (2020-2025) & ($ millions)
Figure 16. Female Sexual Dysfunction Treatment in Sexual Pain Disorders
Figure 17. Global Female Sexual Dysfunction Treatment Market: Sexual Pain Disorders (2020-2025) & ($ millions)
Figure 18. Female Sexual Dysfunction Treatment in Post-orgasmic Diseases
Figure 19. Global Female Sexual Dysfunction Treatment Market: Post-orgasmic Diseases (2020-2025) & ($ millions)
Figure 20. Female Sexual Dysfunction Treatment in Pelvic Floor Dysfunction
Figure 21. Global Female Sexual Dysfunction Treatment Market: Pelvic Floor Dysfunction (2020-2025) & ($ millions)
Figure 22. Female Sexual Dysfunction Treatment in Other
Figure 23. Global Female Sexual Dysfunction Treatment Market: Other (2020-2025) & ($ millions)
Figure 24. Global Female Sexual Dysfunction Treatment Market Size Market Share by Application in 2024
Figure 25. Global Female Sexual Dysfunction Treatment Revenue Market Share by Player in 2024
Figure 26. Global Female Sexual Dysfunction Treatment Market Size Market Share by Region (2020-2025)
Figure 27. Americas Female Sexual Dysfunction Treatment Market Size 2020-2025 ($ millions)
Figure 28. APAC Female Sexual Dysfunction Treatment Market Size 2020-2025 ($ millions)
Figure 29. Europe Female Sexual Dysfunction Treatment Market Size 2020-2025 ($ millions)
Figure 30. Middle East & Africa Female Sexual Dysfunction Treatment Market Size 2020-2025 ($ millions)
Figure 31. Americas Female Sexual Dysfunction Treatment Value Market Share by Country in 2024
Figure 32. United States Female Sexual Dysfunction Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. Canada Female Sexual Dysfunction Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Mexico Female Sexual Dysfunction Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. Brazil Female Sexual Dysfunction Treatment Market Size Growth 2020-2025 ($ millions)
Figure 36. APAC Female Sexual Dysfunction Treatment Market Size Market Share by Region in 2024
Figure 37. APAC Female Sexual Dysfunction Treatment Market Size Market Share by Type (2020-2025)
Figure 38. APAC Female Sexual Dysfunction Treatment Market Size Market Share by Application (2020-2025)
Figure 39. China Female Sexual Dysfunction Treatment Market Size Growth 2020-2025 ($ millions)
Figure 40. Japan Female Sexual Dysfunction Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. South Korea Female Sexual Dysfunction Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. Southeast Asia Female Sexual Dysfunction Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. India Female Sexual Dysfunction Treatment Market Size Growth 2020-2025 ($ millions)
Figure 44. Australia Female Sexual Dysfunction Treatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Europe Female Sexual Dysfunction Treatment Market Size Market Share by Country in 2024
Figure 46. Europe Female Sexual Dysfunction Treatment Market Size Market Share by Type (2020-2025)
Figure 47. Europe Female Sexual Dysfunction Treatment Market Size Market Share by Application (2020-2025)
Figure 48. Germany Female Sexual Dysfunction Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. France Female Sexual Dysfunction Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. UK Female Sexual Dysfunction Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Italy Female Sexual Dysfunction Treatment Market Size Growth 2020-2025 ($ millions)
Figure 52. Russia Female Sexual Dysfunction Treatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Middle East & Africa Female Sexual Dysfunction Treatment Market Size Market Share by Region (2020-2025)
Figure 54. Middle East & Africa Female Sexual Dysfunction Treatment Market Size Market Share by Type (2020-2025)
Figure 55. Middle East & Africa Female Sexual Dysfunction Treatment Market Size Market Share by Application (2020-2025)
Figure 56. Egypt Female Sexual Dysfunction Treatment Market Size Growth 2020-2025 ($ millions)
Figure 57. South Africa Female Sexual Dysfunction Treatment Market Size Growth 2020-2025 ($ millions)
Figure 58. Israel Female Sexual Dysfunction Treatment Market Size Growth 2020-2025 ($ millions)
Figure 59. Turkey Female Sexual Dysfunction Treatment Market Size Growth 2020-2025 ($ millions)
Figure 60. GCC Countries Female Sexual Dysfunction Treatment Market Size Growth 2020-2025 ($ millions)
Figure 61. Americas Female Sexual Dysfunction Treatment Market Size 2026-2031 ($ millions)
Figure 62. APAC Female Sexual Dysfunction Treatment Market Size 2026-2031 ($ millions)
Figure 63. Europe Female Sexual Dysfunction Treatment Market Size 2026-2031 ($ millions)
Figure 64. Middle East & Africa Female Sexual Dysfunction Treatment Market Size 2026-2031 ($ millions)
Figure 65. United States Female Sexual Dysfunction Treatment Market Size 2026-2031 ($ millions)
Figure 66. Canada Female Sexual Dysfunction Treatment Market Size 2026-2031 ($ millions)
Figure 67. Mexico Female Sexual Dysfunction Treatment Market Size 2026-2031 ($ millions)
Figure 68. Brazil Female Sexual Dysfunction Treatment Market Size 2026-2031 ($ millions)
Figure 69. China Female Sexual Dysfunction Treatment Market Size 2026-2031 ($ millions)
Figure 70. Japan Female Sexual Dysfunction Treatment Market Size 2026-2031 ($ millions)
Figure 71. Korea Female Sexual Dysfunction Treatment Market Size 2026-2031 ($ millions)
Figure 72. Southeast Asia Female Sexual Dysfunction Treatment Market Size 2026-2031 ($ millions)
Figure 73. India Female Sexual Dysfunction Treatment Market Size 2026-2031 ($ millions)
Figure 74. Australia Female Sexual Dysfunction Treatment Market Size 2026-2031 ($ millions)
Figure 75. Germany Female Sexual Dysfunction Treatment Market Size 2026-2031 ($ millions)
Figure 76. France Female Sexual Dysfunction Treatment Market Size 2026-2031 ($ millions)
Figure 77. UK Female Sexual Dysfunction Treatment Market Size 2026-2031 ($ millions)
Figure 78. Italy Female Sexual Dysfunction Treatment Market Size 2026-2031 ($ millions)
Figure 79. Russia Female Sexual Dysfunction Treatment Market Size 2026-2031 ($ millions)
Figure 80. Egypt Female Sexual Dysfunction Treatment Market Size 2026-2031 ($ millions)
Figure 81. South Africa Female Sexual Dysfunction Treatment Market Size 2026-2031 ($ millions)
Figure 82. Israel Female Sexual Dysfunction Treatment Market Size 2026-2031 ($ millions)
Figure 83. Turkey Female Sexual Dysfunction Treatment Market Size 2026-2031 ($ millions)
Figure 84. Global Female Sexual Dysfunction Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 85. Global Female Sexual Dysfunction Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 86. GCC Countries Female Sexual Dysfunction Treatment Market Size 2026-2031 ($ millions)